Literature DB >> 18844687

Molecular epidemiology of hepatitis B virus in Iran.

S R Mohebbi1, S Amini-Bavil-Olyaee, N Zali, B Noorinayer, F Derakhshan, M Chiani, M Rostami Nejad, M H Antikchi, F Sabahi, M R Zali.   

Abstract

Hepatitis B virus (HBV) infection is a major cause of liver disease worldwide. Eight genotypes and 24 subgenotypes of HBV have been identified. The aim of this study was to determine the distribution of HBV genotypes, subgenotypes and subtypes, and to understand HBV genetic variability in the HBV genome circulating in Iranian provinces. Two hundred and forty-nine sera from HBV-infected patients living in 25 provinces of Iran were collected (2004-2007). A part of the HBV S/pol and whole BCP/C genes were amplified, sequenced and then subjected to phylogenetic, recombination and genetic variability analysis. Results revealed genotype D of HBV in all samples and subgenotypes D1 (98.52%), D2 (0.74%) and D3 (0.74%) among Iranian patients living in different provinces of Iran. Subtypes ayw2 (94.4%), ayw1 (2.8%), ayw3 (2%) and ayw4 (0.4%) were deduced, on the basis of HBV small surface antigen (HBsAg) amino acid sequences. The mean percentage intra-genotypic distance of S plus core regions was 2.8%; the mean percentage inter-genotypic distance of this region between Iranian strains and genotype D isolates was 3.1%; and this rate for other genotypes was 5.2-11.4%. Various rates of point mutations have been found within different HBV genes, e.g. HBsAg (17.2%), precore-G1896A (59.5%) and Basal core promoter (BCP) double mutations (49.2%), whereas no recombination was found. In conclusion, these results indicate that the only genotype circulating in the provinces of Iran is genotype D. There exist high genetic variabilities in the S/pol and BCP/C regions among the Iranian HBV isolates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18844687     DOI: 10.1111/j.1469-0691.2008.02053.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  32 in total

1.  Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients.

Authors:  Golnaz Bahramali; Majid Sadeghizadeh; Samad Amini-Bavil-Olyaee; Seyed-Moayed Alavian; Abbas Behzad-Behbahani; Ahmad Adeli; Mohammad-Reza Aghasadeghi; Safieh Amini; Fereidoun Mahboudi
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

2.  Unique hepatitis B virus subgenotype in a primitive tribal community in eastern India.

Authors:  Sumantra Ghosh; Priyanka Banerjee; Arindam RoyChoudhury; Sumanta Sarkar; Alip Ghosh; Amal Santra; Soma Banerjee; Kausik Das; Bhagirathi Dwibedi; Shantanu K Kar; Vikas Gangadhar Rao; Jyothi T Bhat; Neeru Singh; Abhijit Chowdhury; Simanti Datta
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

3.  Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression.

Authors:  Dake Zhang; Sufang Ma; Xin Zhang; Hanqing Zhao; Huiguo Ding; Changqing Zeng
Journal:  BMC Infect Dis       Date:  2010-09-16       Impact factor: 3.090

4.  Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan.

Authors:  Abbas Ali Husseini; Khwaja Mir Islam Saeed; Esra Yurdcu; A Mithat Bozdayı
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

5.  Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro.

Authors:  Frank Tacke; Elham Shirvani-Dastgerdi
Journal:  Hepat Mon       Date:  2012-06-30       Impact factor: 0.660

6.  Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?

Authors:  Elisabeth Smolle; Evelyn Zöhrer; Kira Bettermann; Johannes Haybaeck
Journal:  Hepat Mon       Date:  2012-10-30       Impact factor: 0.660

7.  Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt.

Authors:  Rania Kishk; Nader Nemr; Abeer Elkady; Mohamed Mandour; Mohamed Aboelmagd; Nevene Ramsis; Mohamed Hassan; Nashaat Soliman; Sayuki Iijima; Shuko Murakami; Yasuhito Tanaka; Mostafa Ragheb
Journal:  Virol J       Date:  2015-09-30       Impact factor: 4.099

8.  Lack of Association Between Transforming Growth Factor Beta 1 -509C/T and +915G/C Polymorphisms and Chronic Hepatitis B in Iranian Patients.

Authors:  Armin Hosseini Razavi; Pedram Azimzadeh; Seyed Reza Mohebbi; Seyed Masoud Hosseini; Sara Romani; Mahsa Khanyaghma; Yasin Hatami; Afsaneh Sharifian; Mohammad Reza Zali
Journal:  Hepat Mon       Date:  2014-04-07       Impact factor: 0.660

9.  Hepatitis B genotypes in iran.

Authors:  Mohammad Reza Haghshenas; Mohsen Arabi; Tahoora Mousavi
Journal:  Mater Sociomed       Date:  2014-04-11

10.  Diagnostic validity of the chemiluminescent method compared to polymerase chain reaction for hepatitis B virus detection in the routine clinical diagnostic laboratory.

Authors:  Mohammad-Hassan Khadem-Ansari; Mir-Davood Omrani; Yousef Rasmi; Arsalan Ghavam
Journal:  Adv Biomed Res       Date:  2014-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.